{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:06:46Z","timestamp":1787890006570,"version":"build-2784847793"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bcp.2021.114847","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T10:51:01Z","timestamp":1637232661000},"page":"114847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders"],"prefix":"10.1016","volume":"195","author":[{"given":"Upasana","family":"Parthasarathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth H.","family":"Vollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Therien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114847_b0005","unstructured":"World Health Organization (WHO) | Coronavirus (COVID-19) Dashboard. https:\/\/covid19whoint\/. 2021."},{"issue":"3","key":"10.1016\/j.bcp.2021.114847_b0010","first-page":"135","article-title":"Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nature reviews","volume":"17","author":"Stefan","year":"2021","journal-title":"Endocrinology."},{"issue":"4","key":"10.1016\/j.bcp.2021.114847_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nature medicine."},{"issue":"10266","key":"10.1016\/j.bcp.2021.114847_b0020","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(20)32662-3","article-title":"Facing up to long COVID","volume":"396","author":"The Lancet","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bcp.2021.114847_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Frontiers in microbiology."},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41591-021-01230-y","article-title":"Looking beyond COVID-19 vaccine phase 3 trials","volume":"27","author":"Kim","year":"2021","journal-title":"Nature medicine."},{"key":"10.1016\/j.bcp.2021.114847_b0035","unstructured":"U.S. Food & Drug Administration (FDA) | COVID-19 Vaccines. https:\/\/wwwfdagov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/covid-19-vaccines. 2021."},{"key":"10.1016\/j.bcp.2021.114847_b0040","unstructured":"World Health Organization (WHO) | COVID-19 vaccine tracker and landscape. https:\/\/wwwwhoint\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines. 2021."},{"key":"10.1016\/j.bcp.2021.114847_b0045","unstructured":"National Institute of Health (NIH) | Anti-SARS-CoV-2 Monoclonal Antibodies; COVID-19 Treatment Guidelines. https:\/\/wwwcovid19treatmentguidelinesnihgov\/therapies\/anti-sars-cov-2-antibody-products\/anti-sars-cov-2-monoclonal-antibodies\/. 2021."},{"key":"10.1016\/j.bcp.2021.114847_b0050","year":"2021","journal-title":"COVID-19 Treatment Guidelines."},{"issue":"7798","key":"10.1016\/j.bcp.2021.114847_b0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.bcp.2021.114847_b0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.stemcr.2020.09.003","article-title":"Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells","volume":"16","author":"Sch\u00e4fer","year":"2021","journal-title":"Stem cell reports."},{"issue":"6499","key":"10.1016\/j.bcp.2021.114847_b0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science (New York, NY)."},{"issue":"5","key":"10.1016\/j.bcp.2021.114847_b0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nature medicine."},{"key":"10.1016\/j.bcp.2021.114847_b0075","doi-asserted-by":"crossref","first-page":"110195","DOI":"10.1016\/j.biopha.2020.110195","article-title":"New understanding of the damage of SARS-CoV-2 infection outside the respiratory system","volume":"127","author":"Zhang","year":"2020","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie."},{"issue":"4","key":"10.1016\/j.bcp.2021.114847_b0080","article-title":"Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2","volume":"37","author":"Bullen","year":"2020","journal-title":"ALTEX."},{"key":"10.1016\/j.bcp.2021.114847_b0085","doi-asserted-by":"crossref","unstructured":"Bojkova D, Wagner JUG, Shumliakivska M, Aslan GS, Saleem U, Hansen A, et al. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovascular research. 2020;116(14).","DOI":"10.1093\/cvr\/cvaa267"},{"key":"10.1016\/j.bcp.2021.114847_b0090","doi-asserted-by":"crossref","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet (London, England). 2020;395(10234).","DOI":"10.1016\/S0140-6736(20)30937-5"},{"key":"10.1016\/j.bcp.2021.114847_b0095","article-title":"Siglec-1 on dendritic cells mediates SARS-CoV-2 trans-infection of target cells while on macrophages triggers proinflammatory responses","author":"Perez-Zsolt","year":"2021","journal-title":"BioRxiv 443572 [Preprint]. Available from"},{"issue":"18","key":"10.1016\/j.bcp.2021.114847_b0100","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"The New England journal of medicine."},{"key":"10.1016\/j.bcp.2021.114847_b0105","unstructured":"Centers for Disease Control and Prevention (CDC) | COVID-19 Mortality Overview. NVSS - Provisional Death Counts for COVID-19 - Executive Summary. https:\/\/wwwcdcgov\/nchs\/covid19\/mortality-overviewhtm. 2021."},{"issue":"7860","key":"10.1016\/j.bcp.2021.114847_b0110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-021-03475-6","article-title":"The spatial landscape of lung pathology during COVID-19 progression","volume":"593","author":"Rendeiro","year":"2021","journal-title":"Nature."},{"key":"10.1016\/j.bcp.2021.114847_b0115","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.eclinm.2020.100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series","volume":"24","author":"Rapkiewicz","year":"2020","journal-title":"EClinicalMedicine."},{"issue":"5","key":"10.1016\/j.bcp.2021.114847_b0120","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M20-2566","article-title":"Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series","volume":"173","author":"Lax","year":"2020","journal-title":"Annals of internal medicine."},{"key":"10.1016\/j.bcp.2021.114847_b0125","article-title":"Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients","author":"Voeght","year":"2020","journal-title":"MedRxiv 20115873 [Preprint]. Available from"},{"key":"10.1016\/j.bcp.2021.114847_b0130","doi-asserted-by":"crossref","unstructured":"Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11).","DOI":"10.1182\/blood.2020007214"},{"key":"10.1016\/j.bcp.2021.114847_b0135","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine."},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nature reviews Immunology."},{"key":"10.1016\/j.bcp.2021.114847_b0145","article-title":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2019","journal-title":"Frontiers in immunology."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.bcp.2021.114847_b0155","doi-asserted-by":"crossref","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science (New York, NY). 2020;369(6504).","DOI":"10.1126\/science.abc6027"},{"issue":"5","key":"10.1016\/j.bcp.2021.114847_b0160","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell."},{"issue":"10","key":"10.1016\/j.bcp.2021.114847_b0165","article-title":"Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs","volume":"218","author":"Lopez","year":"2021","journal-title":"The Journal of experimental medicine."},{"key":"10.1016\/j.bcp.2021.114847_b0170","volume":"370","author":"Bastard","year":"2020"},{"issue":"10","key":"10.1016\/j.bcp.2021.114847_b0175","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41577-020-00429-3","article-title":"The type I interferon response in COVID-19: implications for treatment","volume":"20","author":"Lee","year":"2020","journal-title":"Nature reviews Immunology."},{"issue":"49","key":"10.1016\/j.bcp.2021.114847_b0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Science immunology."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell host & microbe."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.10.037","article-title":"Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19","volume":"183","author":"Su","year":"2020","journal-title":"Cell."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.11.017","article-title":"Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19","volume":"53","author":"Bernardes","year":"2020","journal-title":"Immunity."},{"issue":"24","key":"10.1016\/j.bcp.2021.114847_b0200","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105896","article-title":"Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage","volume":"39","author":"Chen","year":"2020","journal-title":"The EMBO journal."},{"issue":"10","key":"10.1016\/j.bcp.2021.114847_b0205","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nature medicine."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0210","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell."},{"issue":"8","key":"10.1016\/j.bcp.2021.114847_b0215","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nature biotechnology."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0220","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jinf.2020.04.002","article-title":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","volume":"81","author":"Liu","year":"2020","journal-title":"The Journal of infection."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-020-00723-1","article-title":"Abnormal immunity of non-survivors with COVID-19: predictors for mortality","volume":"9","author":"Zhao","year":"2020","journal-title":"Infectious diseases of poverty."},{"issue":"12","key":"10.1016\/j.bcp.2021.114847_b0230","first-page":"2279","article-title":"Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical","volume":"39","author":"Zhao","year":"2020","journal-title":"Microbiology."},{"issue":"9","key":"10.1016\/j.bcp.2021.114847_b0235","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41423-020-0492-x","article-title":"Elevated serum levels of S100A8\/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients","volume":"17","author":"Chen","year":"2020","journal-title":"Cellular & Molecular Immunology."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0240","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nature medicine."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0245","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nature reviews Immunology."},{"key":"10.1016\/j.bcp.2021.114847_b0250","doi-asserted-by":"crossref","unstructured":"Zhang D, Guo R, Lei L, Liu H, Wang Y, Wang Y, et al. Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. Journal of leukocyte biology. 2021;109(1).","DOI":"10.1002\/JLB.4HI0720-470R"},{"key":"10.1016\/j.bcp.2021.114847_b0255","article-title":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. National Science","author":"Zhou","year":"2020","journal-title":"Review."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0260","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell discovery."},{"key":"10.1016\/j.bcp.2021.114847_b0265","doi-asserted-by":"crossref","unstructured":"Lee JW, Su Y, Baloni P, Chen D, Pavlovitch-Bedzyk AJ, Yuan D, et al. Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nature biotechnology. 2021.","DOI":"10.1038\/s41587-021-01020-4"},{"key":"10.1016\/j.bcp.2021.114847_b0270","article-title":"Tryptophan and arginine metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: findings from longitudinal targeted metabolomics analysis","author":"Ansone","year":"2021","journal-title":"MedRxiv 21254699 [Preprint]. Available from"},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0275","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73966-5","article-title":"The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism","volume":"10","author":"Blasco","year":"2020","journal-title":"Scientific reports."},{"key":"10.1016\/j.bcp.2021.114847_b0280","series-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","article-title":"Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge","author":"Xu","year":"2021"},{"key":"10.1016\/j.bcp.2021.114847_b0285","doi-asserted-by":"crossref","unstructured":"Li B-W, Fan X, Cao W-J, Tian H, Wang S-Y, Zhang J-Y, et al. Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19. Infectious Diseases & Immunity. 2021.","DOI":"10.1097\/ID9.0000000000000010"},{"key":"10.1016\/j.bcp.2021.114847_b0290","doi-asserted-by":"crossref","unstructured":"Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI insight. 2020;5(11).","DOI":"10.1172\/jci.insight.138999"},{"key":"10.1016\/j.bcp.2021.114847_b0295","doi-asserted-by":"crossref","unstructured":"Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, Lima Md, Nascimento DC, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. The Journal of experimental medicine. 2020;217(12).","DOI":"10.1084\/jem.20201129"},{"key":"10.1016\/j.bcp.2021.114847_b0300","doi-asserted-by":"crossref","unstructured":"Middleton EA, He X-Y, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10).","DOI":"10.1182\/blood.2020007008"},{"key":"10.1016\/j.bcp.2021.114847_b0305","doi-asserted-by":"crossref","unstructured":"Borges L, Pithon-Curi TC, Curi R, Hatanaka E. Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19. Frontiers in immunology. 2020;11.","DOI":"10.3389\/fimmu.2020.02063"},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0310","first-page":"988","volume":"41","author":"Ng","year":"2021","journal-title":"Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Arteriosclerosis, thrombosis, and vascular biology."},{"key":"10.1016\/j.bcp.2021.114847_b0315","doi-asserted-by":"crossref","unstructured":"Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, et al. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019. The Journal of infectious diseases. 2021;223(6).","DOI":"10.1093\/infdis\/jiaa756"},{"issue":"18","key":"10.1016\/j.bcp.2021.114847_b0320","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.120.050656","article-title":"Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19","volume":"142","author":"Busch","year":"2020","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.bcp.2021.114847_b0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1710-1492-2-3-98","article-title":"Mechanisms of degranulation in neutrophils","volume":"2","author":"Lacy","year":"2006","journal-title":"Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology."},{"key":"10.1016\/j.bcp.2021.114847_b0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fimmu.2013.00045","article-title":"NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury","volume":"4","author":"Almyroudis","year":"2013","journal-title":"Front Immunol."},{"issue":"9530","key":"10.1016\/j.bcp.2021.114847_b0335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(06)69005-3","article-title":"Neutrophils in development of multiple organ failure in sepsis","volume":"368","author":"Brown","year":"2006","journal-title":"Lancet."},{"issue":"10","key":"10.1016\/j.bcp.2021.114847_b0340","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00134-013-3054-1","article-title":"Endothelial injury in sepsis","volume":"39","author":"Levi","year":"2013","journal-title":"Intensive care medicine."},{"issue":"3","key":"10.1016\/j.bcp.2021.114847_b0345","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF02592978","article-title":"Neutrophil activation by adhesion: mechanisms and pathophysiological implications","volume":"26","author":"Berton","year":"1996","journal-title":"International journal of clinical & laboratory research."},{"issue":"8","key":"10.1016\/j.bcp.2021.114847_b0350","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1096\/fasebj.8.8.8181668","article-title":"Adhesion molecules and inflammatory injury","volume":"8","author":"Albelda","year":"1994","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology."},{"issue":"3","key":"10.1016\/j.bcp.2021.114847_b0355","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jlb.65.3.313","article-title":"Integrin signal transduction in myeloid leukocytes","volume":"65","author":"Lowell","year":"1999","journal-title":"Journal of leukocyte biology."},{"issue":"11","key":"10.1016\/j.bcp.2021.114847_b0360","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.it.2009.07.012","article-title":"Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability","volume":"30","author":"DiStasi","year":"2009","journal-title":"Trends in immunology."},{"issue":"5 Pt 1","key":"10.1016\/j.bcp.2021.114847_b0365","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1083\/jcb.111.5.2171","article-title":"Tumor necrosis factor and CD11\/CD18 (beta 2) integrins act synergistically to lower cAMP in human neutrophils","volume":"111","author":"Nathan","year":"1990","journal-title":"J Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0370","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4049\/jimmunol.152.1.290","article-title":"Exocytosis of a subpopulation of specific granules coincides with H2O2 production in adherent human neutrophils","volume":"152","author":"Suchard","year":"1994","journal-title":"J Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0375","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.162.2.1120","article-title":"Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck","volume":"162","author":"Mocsai","year":"1999","journal-title":"J Immunol."},{"issue":"8660","key":"10.1016\/j.bcp.2021.114847_b0380","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(89)90591-6","article-title":"Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome","volume":"334","author":"Forsyth","year":"1989","journal-title":"Lancet."},{"issue":"8","key":"10.1016\/j.bcp.2021.114847_b0385","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","article-title":"Neutrophil extracellular trap (NET) impact on deep vein thrombosis","volume":"32","author":"Fuchs","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0390","doi-asserted-by":"crossref","first-page":"e22946","DOI":"10.4161\/onci.22946","article-title":"Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression","volume":"2","author":"Demers","year":"2013","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.bcp.2021.114847_b0395","doi-asserted-by":"crossref","unstructured":"Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2013.","DOI":"10.1182\/blood-2013-10-463646"},{"issue":"5","key":"10.1016\/j.bcp.2021.114847_b0400","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1083\/jcb.201203170","article-title":"Neutrophil extracellular traps: is immunity the second function of chromatin?","volume":"198","author":"Brinkmann","year":"2012","journal-title":"J Cell Biol."},{"issue":"16","key":"10.1016\/j.bcp.2021.114847_b0405","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2013-04-457671","article-title":"NETosis: how vital is it?","volume":"122","author":"Yipp","year":"2013","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.bcp.2021.114847_b0410","doi-asserted-by":"crossref","first-page":"1701389","DOI":"10.1183\/13993003.01389-2017","article-title":"Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial","volume":"51","author":"Ebrahimi","year":"2018","journal-title":"The European respiratory journal."},{"key":"10.1016\/j.bcp.2021.114847_b0415","doi-asserted-by":"crossref","unstructured":"Zucoloto AZ, Jenne CN. Platelet-Neutrophil Interplay: Insights Into Neutrophil Extracellular Trap (NET)-Driven Coagulation in Infection. Frontiers in cardiovascular medicine. 2019;6.","DOI":"10.3389\/fcvm.2019.00085"},{"key":"10.1016\/j.bcp.2021.114847_b0420","doi-asserted-by":"crossref","unstructured":"Grasselli G, Tonetti T, Filippini C, Slutsky AS, Pesenti A, Ranieri VM. Pathophysiology of COVID-19-associated acute respiratory distress syndrome. The Lancet Respiratory Medicine. 2021;9(1).","DOI":"10.1016\/S2213-2600(20)30525-7"},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0425","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41418-018-0172-x","article-title":"Necroptosis in anti-viral inflammation","volume":"26","author":"Nailwal","year":"2019","journal-title":"Cell death and differentiation."},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0430","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/mi.2013.77","article-title":"DAMPs activating innate and adaptive immune responses in COPD","volume":"7","author":"Pouwels","year":"2014","journal-title":"Mucosal immunology."},{"issue":"3","key":"10.1016\/j.bcp.2021.114847_b0435","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41435-021-00140-w","article-title":"Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia","volume":"22","author":"Land","year":"2021","journal-title":"Genes and immunity."},{"key":"10.1016\/j.bcp.2021.114847_b0440","doi-asserted-by":"crossref","unstructured":"Huckriede J, Anderberg SB, Morales A, Vries Fd, Hultstr\u00f6m M, Bergqvist A, et al. Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients. Scientific reports. 2021;11(1).","DOI":"10.1038\/s41598-021-95209-x"},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0445","article-title":"Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia. Critical care (London","volume":"22","author":"Mikacenic","year":"2018","journal-title":"England)"},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0450","doi-asserted-by":"crossref","DOI":"10.1186\/2052-0492-2-32","article-title":"Pathophysiology and biomarkers of acute respiratory distress syndrome","volume":"2","author":"Fujishima","year":"2014","journal-title":"Journal of intensive care."},{"key":"10.1016\/j.bcp.2021.114847_b0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediators of inflammation."},{"key":"10.1016\/j.bcp.2021.114847_b0460","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 Inflammasome in Severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Frontiers in immunology."},{"issue":"12","key":"10.1016\/j.bcp.2021.114847_b0465","doi-asserted-by":"crossref","first-page":"e05672","DOI":"10.1016\/j.heliyon.2020.e05672","article-title":"HMGB1 as a potential biomarker and therapeutic target for severe COVID-19","volume":"6","author":"Chen","year":"2020","journal-title":"Heliyon."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0470","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75618-0","article-title":"Serum S100B protein as a marker of severity in Covid-19 patients","volume":"10","author":"Aceti","year":"2020","journal-title":"Scientific reports."},{"key":"10.1016\/j.bcp.2021.114847_b0475","doi-asserted-by":"crossref","unstructured":"Fan X, Song J-W, Wang S-Y, Cao W-J, Wang X-W, Zhou M-J, et al. Changes of Damage Associated Molecular Patterns in COVID-19 Patients. Infectious Diseases & Immunity. 2021.","DOI":"10.1097\/01.ID9.0000733572.40970.6c"},{"key":"10.1016\/j.bcp.2021.114847_b0480","doi-asserted-by":"crossref","unstructured":"Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O'Halloran JA, et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI insight. 2021;6(4).","DOI":"10.1172\/jci.insight.143299"},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0485","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.chom.2020.12.016","article-title":"Induction of alarmin S100A8\/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19","volume":"29","author":"Guo","year":"2021","journal-title":"Cell host & microbe."},{"key":"10.1016\/j.bcp.2021.114847_b0490","article-title":"Neutrophil calprotectin identifies severe pulmonary disease in COVID-19","author":"Shi","year":"2020","journal-title":"Journal of Leukocyte Biology"},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0495","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nri3682","article-title":"Post-transcriptional regulation of gene expression in innate immunity","volume":"14","author":"Carpenter","year":"2014","journal-title":"Nature reviews Immunology."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0500","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2015.8","article-title":"Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease","volume":"16","author":"Cao","year":"2016","journal-title":"Nature reviews Immunology."},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0505","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbrc.2006.02.005","article-title":"SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages","volume":"342","author":"Hardin","year":"2006","journal-title":"Biochemical and biophysical research communications."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0510","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.immuni.2006.10.014","article-title":"SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production","volume":"25","author":"An","year":"2006","journal-title":"Immunity."},{"issue":"4","key":"10.1016\/j.bcp.2021.114847_b0515","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nature reviews Immunology."},{"key":"10.1016\/j.bcp.2021.114847_b0520","doi-asserted-by":"crossref","first-page":"110168","DOI":"10.1016\/j.mehy.2020.110168","article-title":"Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5\/14","volume":"144","author":"Murch","year":"2020","journal-title":"Medical hypotheses."},{"key":"10.1016\/j.bcp.2021.114847_b0525","article-title":"Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota","author":"Chiodo","year":"2020","journal-title":"BioRxiv 092478 [Preprint]. Available from"},{"key":"10.1016\/j.bcp.2021.114847_b0530","doi-asserted-by":"crossref","unstructured":"Carlin AF, Uchiyama S, Chang Y-C, Lewis AL, Nizet V, Varki A. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood. 2009;113(14).","DOI":"10.1182\/blood-2008-11-187302"},{"key":"10.1016\/j.bcp.2021.114847_b0535","doi-asserted-by":"crossref","unstructured":"Aschenbrenner AC, Mouktaroudi M, Kr\u00e4mer B, Oestreich M, Antonakos N, Nuesch-Germano M, et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome medicine. 2021;13(1).","DOI":"10.1186\/s13073-020-00823-5"},{"issue":"4","key":"10.1016\/j.bcp.2021.114847_b0540","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/acscentsci.0c01669","article-title":"Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19","volume":"7","author":"Delaveris","year":"2021","journal-title":"ACS central science."},{"key":"10.1016\/j.bcp.2021.114847_b0545","doi-asserted-by":"crossref","unstructured":"Chen G-Y, Tang J, Zheng P, Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science (New York, NY). 2009;323(5922).","DOI":"10.1126\/science.1168988"},{"issue":"7","key":"10.1016\/j.bcp.2021.114847_b0550","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ni.2610","article-title":"T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10","volume":"14","author":"Bandala-Sanchez","year":"2013","journal-title":"Nature immunology."},{"issue":"6162","key":"10.1016\/j.bcp.2021.114847_b0555","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/332323a0","article-title":"Reshaping human antibodies for therapy","volume":"332","author":"Riechmann","year":"1988","journal-title":"Nature."},{"issue":"11","key":"10.1016\/j.bcp.2021.114847_b0560","first-page":"927","article-title":"Different mechanisms of Campath-1H-mediated depletion for CD4 and CD8 T cells in peripheral blood. Transplant international : official journal of the European Society for Organ","volume":"19","author":"Lowenstein","year":"2006","journal-title":"Transplantation."},{"key":"10.1016\/j.bcp.2021.114847_b0565","doi-asserted-by":"crossref","unstructured":"Fiorella C, Lorna G. COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID. Multiple sclerosis and related disorders. 2020;46.","DOI":"10.1016\/j.msard.2020.102447"},{"key":"10.1016\/j.bcp.2021.114847_b0570","doi-asserted-by":"crossref","unstructured":"Guevara C, Villa E, Cifuentes M, Naves R, Graziaa Jd. Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab. Multiple sclerosis and related disorders. 2020;44.","DOI":"10.1016\/j.msard.2020.102314"},{"key":"10.1016\/j.bcp.2021.114847_b0575","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-D\u00edaz E, Gracia-Gil J, Garc\u00eda-Garc\u00eda JG, Palao M, Romero-S\u00e1nchez CM, Segura T. COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab. Multiple sclerosis and related disorders. 2020;45.","DOI":"10.1016\/j.msard.2020.102402"},{"key":"10.1016\/j.bcp.2021.114847_b0580","doi-asserted-by":"crossref","unstructured":"Mat\u00edas-Guiu J, Montero-Escribano P, Pytel V, Porta-Etessam J, Matias-Guiu JA. Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab. Multiple sclerosis and related disorders. 2020;44.","DOI":"10.1016\/j.msard.2020.102297"},{"key":"10.1016\/j.bcp.2021.114847_b0585","doi-asserted-by":"crossref","unstructured":"Carandini T, Pietroboni AM, Sacchi L, Riz MAD, Pozzato M, Arighi A, et al. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression. Multiple sclerosis (Houndmills, Basingstoke, England). 2020;26(10).","DOI":"10.1177\/1352458520926459"},{"key":"10.1016\/j.bcp.2021.114847_b0590","unstructured":"ClinicalTrials.gov. CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrialsgov\/ct2\/show\/NCT04317040. 2021."},{"key":"10.1016\/j.bcp.2021.114847_b0595","unstructured":"ClinicalTrials.gov. Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrialsgov\/ct2\/show\/NCT04747574. 2021."},{"issue":"7769","key":"10.1016\/j.bcp.2021.114847_b0600","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.bcp.2021.114847_b0605","doi-asserted-by":"crossref","unstructured":"Toubai T, Hou G, Mathewson N, Liu C, Wang Y, Oravecz-Wilson K, et al. Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice. Blood. 2014;123(22).","DOI":"10.1182\/blood-2013-12-545335"},{"issue":"5","key":"10.1016\/j.bcp.2021.114847_b0610","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nbt.1846","article-title":"Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction","volume":"29","author":"Chen","year":"2011","journal-title":"Nature biotechnology."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0615","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/cmi.2013.38","article-title":"CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells","volume":"10","author":"Samten","year":"2013","journal-title":"Cellular & molecular immunology."},{"key":"10.1016\/j.bcp.2021.114847_b0620","doi-asserted-by":"crossref","unstructured":"Bandala-Sanchez E, Bediaga NG, Goddard-Borger ED, Ngui K, Naselli G, Stone NL, et al. CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function. Proceedings of the National Academy of Sciences of the United States of America. 2018;115(30).","DOI":"10.1073\/pnas.1722056115"},{"key":"10.1016\/j.bcp.2021.114847_b0625","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.626820","article-title":"CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function","volume":"11","author":"Bhamidipati","year":"2021","journal-title":"Frontiers in immunology."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0630","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-immunol-020711-075018","article-title":"Siglecs and immune regulation","volume":"30","author":"Pillai","year":"2012","journal-title":"Annual review of immunology."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0635","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","article-title":"Siglecs as Immune Cell Checkpoints in Disease","volume":"38","author":"Duan","year":"2020","journal-title":"Annual review of immunology."},{"key":"10.1016\/j.bcp.2021.114847_b0640","article-title":"Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19. BioRxiv 379115 [Preprint]","author":"Formiga","year":"2020","journal-title":"Available from"},{"issue":"3","key":"10.1016\/j.bcp.2021.114847_b0645","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jmv.25330","article-title":"Combined effect of anti-high-mobility group box-1 monoclonal antibody and peramivir against influenza A virus-induced pneumonia in mice","volume":"91","author":"Hatayama","year":"2019","journal-title":"Journal of medical virology."},{"issue":"1-2","key":"10.1016\/j.bcp.2021.114847_b0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.08.010","article-title":"Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management","volume":"239","author":"Gambuzza","year":"2011","journal-title":"Journal of neuroimmunology."},{"key":"10.1016\/j.bcp.2021.114847_b0655","doi-asserted-by":"crossref","unstructured":"Lloyd C. Chemokines in allergic lung inflammation. Immunology. 2002;105(2).","DOI":"10.1046\/j.1365-2567.2002.01344.x"},{"key":"10.1016\/j.bcp.2021.114847_b0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediators of inflammation."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: Current State of the Science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity."},{"key":"10.1016\/j.bcp.2021.114847_b0670","doi-asserted-by":"crossref","unstructured":"Castelnovo L, Tamburello A, Lurati A, Zaccara E, Marrazza MG, Olivetti M, et al. Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience. Medicine. 2021;100(1).","DOI":"10.1097\/MD.0000000000023582"},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0675","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jmv.26387","article-title":"Targeting human TLRs to combat COVID-19: A solution?","volume":"93","author":"Patra","year":"2021","journal-title":"Journal of medical virology."},{"key":"10.1016\/j.bcp.2021.114847_b0680","doi-asserted-by":"crossref","unstructured":"Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovascular research. 2020;116(14).","DOI":"10.1093\/cvr\/cvaa230"},{"key":"10.1016\/j.bcp.2021.114847_b0685","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thrombosis research."},{"issue":"5","key":"10.1016\/j.bcp.2021.114847_b0690","first-page":"750","volume":"202","author":"Mangalmurti","year":"2020","journal-title":"COVID-19-associated Acute Respiratory Distress Syndrome Clarified: A Vascular Endotype? American journal of respiratory and critical care medicine."},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0695","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"The New England journal of medicine."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0700","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03062-7","article-title":"The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection","volume":"24","author":"Pons","year":"2020","journal-title":"Critical care (London, England)"},{"issue":"12","key":"10.1016\/j.bcp.2021.114847_b0705","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 Transmission and Pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends in immunology."},{"key":"10.1016\/j.bcp.2021.114847_b0710","doi-asserted-by":"crossref","unstructured":"Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS letters. 2010;584(14).","DOI":"10.1016\/j.febslet.2010.06.006"},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0715","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"Journal of immunology (Baltimore, Md"},{"issue":"2","key":"10.1016\/j.bcp.2021.114847_b0720","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.mvr.2010.11.010","article-title":"HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption","volume":"81","author":"Wolfson","year":"2011","journal-title":"Microvascular research."},{"issue":"11","key":"10.1016\/j.bcp.2021.114847_b0725","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.2053","article-title":"Extracellular histones are major mediators of death in sepsis","volume":"15","author":"Xu","year":"2009","journal-title":"Nat Med."},{"issue":"36","key":"10.1016\/j.bcp.2021.114847_b0730","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"10.1016\/j.bcp.2021.114847_b0735","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.chom.2012.06.011","article-title":"Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis","volume":"12","author":"McDonald","year":"2012","journal-title":"Cell host & microbe."},{"issue":"8","key":"10.1016\/j.bcp.2021.114847_b0740","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0745","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med."},{"issue":"4","key":"10.1016\/j.bcp.2021.114847_b0750","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0755","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jlb.66.1.10","article-title":"Neutrophil migration during endotoxemia","volume":"66","author":"Wagner","year":"1999","journal-title":"Journal of leukocyte biology."},{"issue":"4","key":"10.1016\/j.bcp.2021.114847_b0760","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.intimp.2013.10.002","article-title":"Depletion of blood neutrophils from patients with sepsis: treatment for the future?","volume":"17","author":"Lewis","year":"2013","journal-title":"International immunopharmacology."},{"issue":"5","key":"10.1016\/j.bcp.2021.114847_b0765","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0035-8819(25)01464-3","article-title":"Multi-organ dysfunction in the critically ill: effects on different organs","volume":"34","author":"Brealey","year":"2000","journal-title":"Journal of the Royal College of Physicians of London."},{"issue":"12","key":"10.1016\/j.bcp.2021.114847_b0770","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/archsurg.134.12.1367","article-title":"Preferential loss of CXCR-2 receptor expression and function in patients who have undergone trauma","volume":"134","author":"Quaid","year":"1999","journal-title":"Arch Surg."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0775","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jlb.50.6.547","article-title":"Critically ill anergic patients demonstrate polymorphonuclear neutrophil activation in the intravascular compartment with decreased cell delivery to inflammatory focci","volume":"50","author":"Tellado","year":"1991","journal-title":"Journal of leukocyte biology."},{"issue":"12","key":"10.1016\/j.bcp.2021.114847_b0780","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archsurg.1988.01400360089016","article-title":"Whole-body inflammation in trauma patients","volume":"123","author":"Nuytinck","year":"1988","journal-title":"An autopsy study. Arch Surg."},{"key":"10.1016\/j.bcp.2021.114847_b0785","first-page":"S34","article-title":"Pathogenesis of renal failure in sepsis","volume":"66","author":"Thijs","year":"1998","journal-title":"Kidney international Supplement."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0790","doi-asserted-by":"crossref","first-page":"C1592","DOI":"10.1152\/ajpcell.00540.2001","article-title":"A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release","volume":"283","author":"Wyman","year":"2002","journal-title":"American journal of physiology Cell physiology."},{"issue":"1","key":"10.1016\/j.bcp.2021.114847_b0795","doi-asserted-by":"crossref","DOI":"10.1186\/s40560-014-0065-0","article-title":"PAMPs and DAMPs as triggers for DIC","volume":"2","author":"Ito","year":"2014","journal-title":"Journal of intensive care."},{"key":"10.1016\/j.bcp.2021.114847_b0800","doi-asserted-by":"crossref","unstructured":"Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101(7).","DOI":"10.1182\/blood-2002-05-1300"},{"issue":"4","key":"10.1016\/j.bcp.2021.114847_b0805","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2796.2003.01204.x","article-title":"High mobility group 1 B-box mediates activation of human endothelium","volume":"254","author":"Treutiger","year":"2003","journal-title":"Journal of internal medicine."},{"issue":"11","key":"10.1016\/j.bcp.2021.114847_b0810","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1160\/TH14-12-1073","article-title":"HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi","volume":"114","author":"Ahrens","year":"2015","journal-title":"Thrombosis and haemostasis."},{"issue":"6","key":"10.1016\/j.bcp.2021.114847_b0815","first-page":"1355","article-title":"Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice. Hypertension (Dallas","volume":"72","author":"Kawano","year":"2018","journal-title":"Tex"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:26:13Z","timestamp":1757769973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221004639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":163,"alternative-id":["S0006295221004639"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114847","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114847"}}